Products

DESCRIPTION

Basic Info

Model NO.	gabapentin
Powder	Yes
Customized	Non-Customized
Certification	USP
Suitable for	Elderly, Children, Adult
State	Solid
Purity	>99%
Name	Gabapentin
Other Names	Gabapentin Capsules
Other Name	Gabapentin Powder
CAS	60142-96-3
Einecs	262-076-3
Molecular Formula	C9h17no2
Molecular Weight	171.24
Content	98%
Color	White
Form	Powder
Type	API
Grade	Pharma
MOQ	100g
Storage	Cool Dry Place
Shelf Life	2 Years
Transport Package	Foil Bag
Specification	99%
Trademark	TGYBIO
Origin	China
HS Code	2019041703
Production Capacity	20kg/Month

Product Description

Product Name:Gabapentin powderPurity :≥99%Colour: White PowderCAS NO.: 60142-96-3Molecular Formula: C9H17NO2Molecular Weight: 171.24Storage: Store in cool and dry places, keep away from strong light.Gabapentin is structurally similar to GABA (sc-203053; γ-aminobutyric acid) and is reported in various research studies to increase GABA concentrations within the brain. Gabapentin is also noted to bind to a novel site on voltage-sensitive Ca2+ channels.Additionally, Gabapentin is reported to demonstrate inhibition of dopamine release from caudate nucleus, preventneuronal cell death, and is antinociceptive.

Specification:

Product Name		Gabapentin		CAS		60142-96-3
Standard		USP		Country of Origin		China
Lot No		IK201025		Quantity		1000kg
Packaging		Drum		Manufacture Date		Oct 25th,2020
Date Of Test		Oct 26th,2020		Expire Date		Oct 24th,2023
ITEM			SPECIFICATION		RESULT
Description			White or off-white crystalline powder		White crystalline powder
Identification	IR		IR spectrum is consistent with Gabapentin RS		Complies
	HPLC		Conform with the RT of the major peak in HPLC with USP Gabapentin WPS		Complies
PH			6.5~8.0		7.4
Water			≤0.5%		0.04%
Residue on ignition			≤0.1%		0.03%
Heavy metals			≤0.002%		<0.002%
Residual solvents (Ethanol)			≤0.50%		0.01%
Late eluting impurities-Any individual impurity			≤0.10%		Not detected
Total impurities			≤0.5%		0.003%
Assay			98.0%~102.0%		99.9%
Limit of chloride			≤0.01%		0.004%
Conclusion			The product meet the testing requirements

It is used for the additional treatment of epilepsy patients with localized seizures that cannot be satisfactorily controlled or tolerated by conventional antiepileptic drugs and epilepsy patients with localized seizures and subsequent systemic seizures. Anti-anxiety medication.